Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 7, Issue 6 (2018)

Diagnostic evaluation and therapeutic management of dilated cardiomyopathy (DCM) in a Labrador retriever

Author(s):
Saahithya Rajamohan, Harish Lompiyan Janarthanan, M Chandrasekar and K Jeyaraja
Abstract:
A male Labrador retriever of 9 years of age was presented with severe abdominal distension, exercise intolerance and inappetance. On physical examination, tachycardia, weak femoral pulse, fluid thrill on percussion of distended abdomen and dyspnoea were appreciated. Electrocardiography showed atrial fibrillation. In radiograph, cardiomegaly was noticed and vertebral heart score of 12 was measured. Echocardiography was performed.
The dog was diagnosed with Dilated cardiomyopathy. For long time support, it was treated with Pimobendan @ 0.25mg/kg b.wt BID P/O, Diltiazem, a calcium channel blocker @ 2mg/kg b.wt TID P/O along with enalapril maleate @ 0.5mg/kg b.wt and furosemide @ 1.5mg/kg b.wt. The owner was further informed that the treatment was to prolong the life span of dog with better quality of life.
Pages: 509-511  |  669 Views  213 Downloads


The Pharma Innovation Journal
How to cite this article:
Saahithya Rajamohan, Harish Lompiyan Janarthanan, M Chandrasekar, K Jeyaraja. Diagnostic evaluation and therapeutic management of dilated cardiomyopathy (DCM) in a Labrador retriever. Pharma Innovation 2018;7(6):509-511.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter